Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Heiko Schenk is active.

Publication


Featured researches published by Heiko Schenk.


European Journal of Immunology | 2015

The histamine H4-receptor (H4R) regulates eosinophilic inflammation in ovalbumin-induced experimental allergic asthma in mice

Christina Hartwig; Antje Munder; Silke Glage; Dirk Wedekind; Heiko Schenk; Roland Seifert; Detlef Neumann

Via the histamine H4‐receptor (H4R), histamine promotes the pathogenesis of experimental allergic asthma in mice. Application of H4R antagonists during sensitization as well as during provocation reduces the severity of the disease. However, the specific cell types functionally expressing H4R in experimental allergic asthma have not been well characterized in vivo. In this study, we identified the cell type(s) responsible for H4R activity in experimental asthma and related physiological mechanisms. Using H4R‐deficient mice, we studied the role of H4R in the sensitization and effector phase. DCs lacking H4R expression during the in vitro sensitization reaction resulted in effector T cells unable to induce an entire eosinophilic inflammation in the lung upon adoptive transfer in vivo. Recipient mice lacking H4R expression, which were adoptively transferred with H4R+/+ T cells polarized in the presence of H4R+/+ DCs, showed reduced signs of inflammation and ameliorated lung function. Here, we provide in vivo evidence that in experimental asthma in mice the H4R specifically regulates activation of DCs during sensitization, while in the effector phase the H4R is active in cells involved in the activation of eosinophils, and possibly other cells. A putative therapy targeting the H4R may be an option for asthma patients developing IL‐5‐dependent eosinophilia.


Diabetes | 2016

CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.

Beina Teng; Patricia Schroder; Janina Müller-Deile; Heiko Schenk; Lynne Staggs; Irini Tossidou; Ivan Dikic; Hermann Haller; Mario Schiffer

Diabetic nephropathy (DN) is the major cause of end-stage renal disease worldwide. Podocytes are important for glomerular filtration barrier function and maintenance of size selectivity in protein filtration in the kidney. Podocyte damage is the basis of many glomerular diseases characterized by loss of interdigitating foot processes and decreased expression of components of the slit diaphragm. Nephrin, a podocyte-specific protein, is the main component of the slit diaphragm. Loss of nephrin is observed in human and rodent models of diabetic kidney disease. The long isoform of CIN85 (RukL) is a binding partner of nephrin that mediates nephrin endocytosis via ubiquitination in podocytes. Here we demonstrate that the loss of nephrin expression and the onset of proteinuria in diabetic mice correlate with an increased accumulation of ubiquitinated proteins and expression of CIN85/RukL in podocytes. CIN85/RukL deficiency preserved nephrin surface expression on the slit diaphragm and reduced proteinuria in diabetic mice, whereas overexpression of CIN85 in zebrafish induced severe edema and disruption of the filtration barrier. Thus, CIN85/RukL is involved in endocytosis of nephrin in podocytes under diabetic conditions, causing podocyte depletion and promoting proteinuria. CIN85/RukL expression therefore shows potential to be a novel target for antiproteinuric therapy in diabetes.


Cell and Tissue Research | 2017

Disease modeling in genetic kidney diseases: zebrafish

Heiko Schenk; Janina Müller-Deile; Mark Kinast; Mario Schiffer

Growing numbers of translational genomics studies are based on the highly efficient and versatile zebrafish (Danio rerio) vertebrate model. The increasing types of zebrafish models have improved our understanding of inherited kidney diseases, since they not only display pathophysiological changes but also give us the opportunity to develop and test novel treatment options in a high-throughput manner. New paradigms in inherited kidney diseases have been developed on the basis of the distinct genome conservation of approximately 70 % between zebrafish and humans in terms of existing gene orthologs. Several options are available to determine the functional role of a specific gene or gene sets. Permanent genome editing can be induced via complete gene knockout by using the CRISPR/Cas-system, among others, or via transient modification by using various morpholino techniques. Cross-species rescues succeeding knockdown techniques are employed to determine the functional significance of a target gene or a specific mutation. This article summarizes the current techniques and discusses their perspectives.


Cellular Physiology and Biochemistry | 2016

Overexpression of TGF-β Inducible microRNA-143 in Zebrafish Leads to Impairment of the Glomerular Filtration Barrier by Targeting Proteoglycans

Janina Müller-Deile; Finn Gellrich; Heiko Schenk; Patricia Schroder; Jenny Nyström; Johan M. Lorenzen; Hermann Haller; Mario Schiffer

Background: TGF-β is known as an important stress factor of podocytes in glomerular diseases. Apart from activation of direct pro-apoptotic pathways we wanted to analyze micro-RNA (miRs) driven regulation of components involved in the integrity of the glomerular filtration barrier induced by TGF-β. Since miR-143-3p (miR-143) is described as a TGF-β inducible miR in other cell types, we examined this specific miR and its ability to induce glomerular pathology. Methods: We analyzed miR-143 expression in cultured human podocytes after stimulation with TGF-β. We also microinjected zebrafish eggs with a miR-143 mimic or with morpholinos specific for its targets syndecan and versican and compared phenotype and proteinuria development. Results: We detected a time dependent, TGF-β inducible expression of miR-143 in human podocytes. Targets of miR-143 relevant in glomerular biology are syndecans and versican, which are known components of the glycocalyx. We found that syndecan 1 and 4 were predominantly expressed in podocytes while syndecan 3 was largely expressed in glomerular endothelial cells. Versican could be detected in both cell types. After injection of a miR-143 mimic in zebrafish larvae, syndecan 3, 4 and versican were significantly downregulated. Moreover, miR-143 overexpression or versican knockdown by morpholino caused loss of plasma proteins, edema, podocyte effacement and endothelial damage. In contrast, knockdown of syndecan 3 and syndecan 4 had no effects on glomerular filtration barrier. Conclusion: Expression of versican and syndecan isoforms is indispensable for proper barrier function. Podocyte-derived miR-143 is a mediator for paracrine and autocrine cross talk between podocytes and glomerular endothelial cells and can alter expression of glomerular glycocalyx proteins.


Journal of Clinical Apheresis | 2017

Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb

Heiko Schenk; Janina Müller-Deile; Roland Schmitt; Jan Hinrich Bräsen; Hermann Haller; Mario Schiffer

Treatment of primary focal segmental glomerulosclerosis (FSGS) and its recurrence after kidney transplantation associated with rapid deterioration of kidney function remains to be challenging despite advances in immunosuppressive therapy. The presence of circulating factors has been postulated to be a pivotal player in the pathogenesis of FSGS, although suPAR and CLCF‐1 have been identified as the most promising causative factors. The potential therapeutic effect of suPAR elimination in an FSGS patient using CytoSorb, a hemoadsorption device that gained attention in the cytokine elimination in septic patients, was studied. Efficiency of total plasma exchange to remove suPAR was determined. CytoSorb hemoadsorption caused a 27.33% reduction of the suPAR level in a single treatment, whereas total plasma exchange showed a suPAR level reduction of 25.12% (n = 3; 95% confidence interval, 0.2777‐0.8090; P < 0.01), which may indicate therapeutic potential in the treatment of primary FSGS and its recurrence in a kidney transplant.


Immunopharmacology and Immunotoxicology | 2016

Histamine regulates murine primary dendritic cell functions.

Heiko Schenk; Detlef Neumann; Christina Kloth

Abstract Objective and design: The modulation of antigen uptake and activation of dendritic cells (DCs) by histamine may function as a regulator of inflammation. Therefore, we sought to determine the impact of histamine on antigen uptake by and activation of murine DCs. Material and methods: DCs from spleen and lung were either identified by flow cytometry or were immunomagnetically enriched. Cells were stimulated with histamine, and the regulation of MHC-II and co-stimulatory molecule expression (CD80, CD86, and ICOS-L) and antigen uptake were quantified by flow cytometry. Individual contributions of the histamine receptor subtypes were determined by using the antagonists mepyramine (histamine H1-receptor: H1R), famotidine (H2R), and JNJ 7777120 (H4R). Results: Histamine accelerated the uptake of soluble antigen via the H1R, H2R, and H4R in splenic DCs. Co-stimulatory molecule expression was enhanced already by enrichment procedures, thus, the analyses were performed in unseparated cell populations. Histamine enhanced the expression of CD86 and ICOS-L while expression of CD80 was unaffected. Antagonism at H1R, H2R, and H4R and at H1R and H4R reduced the histamine-induced enhanced expression of CD86 and ICOS-L, respectively. Conclusions: Histamine contributes to the regulation of the immunological synapse by stimulation of antigen uptake and activation of DCs via H1R, H2R, and H4R.


Annals of Translational Medicine | 2016

Drugs targeting dynamin can restore cytoskeleton and focal contact alterations of urinary podocytes derived from patients with nephrotic syndrome.

Janina Müller-Deile; Beina Teng; Heiko Schenk; Hermann Haller; Jochen Reiser; Sanja Sever; Mario Schiffer


Nephrology Dialysis Transplantation | 2018

FP154WHEN YOUR PARTNER MAKES YOU SICK. A NEW MODEL TO INDUCE PROTEINURIA IN ZEBRAFISH USING PARABIOSIS

Janina Müller-Deile; Heiko Schenk; Patricia Schroder; Hermann Haller; Mario Schiffer


Nephrology Dialysis Transplantation | 2017

MP487THE ROLE OF NOVEL GENE SH3D21 IN DIABETIC NEPHROPATHY

Heiko Schenk; Irini Schäfer; Lucia Lemaire; Patricia Schroder; Lynne Staggs; Janina Müller-Deile; Beina Teng; Hermann Haller; Mario Schiffer


Nephrology Dialysis Transplantation | 2016

SP122MIR-143 DEPENDENT DOWNREGULATION OF PODOCYTIC AND ENDOTHELIAL GLYCOCALYX PROTEINS CAUSES PROTEINURIA

Janina Müller-Deile; Finn Gellrich; Patricia Schroder; Heiko Schenk; Jenny Nyström; Peidi Liu; Johann Lorenzen; Thomas Thum; Hermann Haller

Collaboration


Dive into the Heiko Schenk's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Patricia Schroder

Mount Desert Island Biological Laboratory

View shared research outputs
Top Co-Authors

Avatar

Beina Teng

Hannover Medical School

View shared research outputs
Top Co-Authors

Avatar

Lynne Staggs

Mount Desert Island Biological Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jenny Nyström

University of Gothenburg

View shared research outputs
Top Co-Authors

Avatar

Andreas Pich

Hannover Medical School

View shared research outputs
Top Co-Authors

Avatar

Antje Munder

Hannover Medical School

View shared research outputs
Researchain Logo
Decentralizing Knowledge